Report: Restrictive drug plan regs cost consumers

April 22, 2015 by Chain Drug Review and Chain Drug Review Devon Herrick, Drug Plan Regulations, National Center for Policy Analysis, preferred pharmacy networks CDR Blog, Videos

Community pharmacies are likely to take exception to some of the findings in a new report from the National Center for Policy Analysis (NCPA), titled “New Drug Plan Regulations Protect Pharmacies, Harm Consumers”. The report by NCPA senior fellow Devon Herrick notes that, compared with hospital and physician care, drug therapy is the most cost-effective